Correlation Between Visa and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Visa and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Visa and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and NLS Pharmaceutics.
Diversification Opportunities for Visa and NLS Pharmaceutics
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Visa and NLS is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Visa i.e., Visa and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Visa and NLS Pharmaceutics
Taking into account the 90-day investment horizon Visa is expected to generate 1.04 times less return on investment than NLS Pharmaceutics. But when comparing it to its historical volatility, Visa Class A is 20.09 times less risky than NLS Pharmaceutics. It trades about 0.35 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1.50 in NLS Pharmaceutics AG on September 1, 2024 and sell it today you would lose (0.50) from holding NLS Pharmaceutics AG or give up 33.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Visa Class A vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Visa Class A |
| NLS Pharmaceutics |
Visa and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and NLS Pharmaceutics
The main advantage of trading using opposite Visa and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
| NLS Pharmaceutics vs. Reviva Pharmaceuticals Holdings | NLS Pharmaceutics vs. GeoVax Labs | NLS Pharmaceutics vs. NLS Pharmaceutics AG | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |